Gilead Sciences, Inc.: A Breakdown Looms for GILD Stock

Gilead Sciences is sitting out the biotech stock rally. In fact, an ugly breakdown looms for the ailing drug stock. Buy GILD stock puts. More 

3 High-Growth ETFs That Are Just Waiting to Explode

Investors have lost their nerve for now, but these growth plays are going to be prime buying grounds the second Wall Street perks up. More 

Biotech Bloodbath: Ditch XBI, IBB for Now

Biotech ETFs IBB and XBI are in a hurt locker right now. Even if you're bullish on biotechs for the long-term, consider a hedge play or two for now. More 

10 Stocks to Buy for a Set-It-and-Forget-It Summer Portfolio

If you actually want to do other things besides sit in front of a computer for the next few months, here's a closer look at the best stocks to buy and hold into August. More 

3 Great ETFs for a Biotech Rebound – BBP CNCR XBI

Biotech stocks and ETFs have recently been rebounding in impressive fashion. Tactical investors might want to take a look at BBP, XBI and CNCR. More 

SPDR S&P Biotech (ETF) (XBI) – The Best Biotech Investment Now

The best biotech stocks are hard to identify, but the XBI ETF allows investors to make a diversified but aggressive bet on small, high-growth biotech stocks. More 

7 Low-Risk Healthcare Stocks to Buy Now

If you're looking for solid stocks to buy in an uncertain market, healthcare offers built-in growth and, often, safe dividends. More